Document:

exv10w2

 

EXHIBIT 10.2

DEX MEDIA, INC.

CORPORATE AIRCRAFT POLICY

Adopted May 19, 2005

Scope

     The Dex Media, Inc. Corporate Aircraft Policy (the “Corporate Aircraft Policy”) is designed to
provide employees of Dex Media, Inc. (the “Company”) with information and guidelines regarding the
use of Company-owned, chartered or leased aircraft (“Corporate Aircraft”), including scheduling
procedures, charges for flights, personal use and authorization procedures.

Purpose

     1. All aircraft use will be for the purpose of facilitating or conducting Company business or
for Company-sponsored or directed activities.

     2. Company policy is to encourage the use of commercial air carriers for travel. While
Corporate Aircraft are for the use of Company employees, as designated by the Company’s Chief
Executive Officer from time to time (each, a “Designated Employee”), judicious consideration must
always be given to alternative means of transportation. If no time or geographical constraints
exist, considerable cost savings to the Company can be realized by the use of commercial air
carriers. Any travel using Corporate Aircraft, whether for business or personal reasons, must be
approved by the Company’s Chief Executive Officer or an Executive Vice President of the Company.

Scheduling Procedures

     1. A request for the use of a Corporate Aircraft may be initiated by any Designated Employee.
Any such request must be accompanied by a written authorization of the Company’s Chief Executive
Officer or an Executive Vice President of the Company.

     2. When more than three Company officers are scheduled to fly on the same Corporate Aircraft,
the requesting employee will determine if conditions warrant making other travel arrangements to
avoid a unique concentration of officers flying on the same aircraft. As a general rule and to
minimize the effect of a transportation accident on the continuity of the Company:

(i) The Chief Executive Officer should not travel on the same aircraft: (a) with both the
Chief Financial Officer and the Chief Operating Officer; (b) with more than two other direct
reports to the Chief Executive Officer; or (c) with more than one third of the total number
of Company directors; and

(ii) Executive Vice Presidents and Senior Vice Presidents should not travel on the same
aircraft with more than two of their direct reports, unless approved by the Chief Executive
Officer.

Charges For Flights

     1. An hourly rate will be established each year based on the fully loaded budgeted cost per
hour for use of Corporate Aircraft for both business and personal use. This cost will be charged to
the internal cost center of the employee using a Corporate Aircraft based on the number of aircraft
hours used. If a chartered Corporate Aircraft is used, the actual cost will be charged to the cost
center of the employee using such Corporate Aircraft.

     2. If a majority of seats on a Corporate Aircraft are occupied by Company employees traveling
on Company business, then the remaining seats may be filled by one or more individuals traveling on
personal business with zero imputed income to such individuals. Any non-employee travel

1

 

on Corporate Aircraft must be approved by the Chief Executive Officer. To determine the level
of imputed income that may apply, please contact the Company’s Tax Department.

     3. Spousal travel on Corporate Aircraft, even if the Corporate Aircraft is being used for a
business purpose, is considered personal in nature, in accordance with Federal tax regulations.
However, the provisions of paragraph 2 above will determine whether any income will be imputed.

     4. Income will be imputed as required for any personal use of Corporate Aircraft. The amount
of imputation will be determined by applying the Standard Industry Fare Level (“SIFL”) rates to the
Aircraft Valuation Formula in the computation of the value of non-business transportation aboard
employer-provided aircraft, as required by the Internal Revenue Service. SIFL rates are revised by
the Department of Transportation every six months and are applied to a formula which considers
mileage, terminal charge and aircraft weight to arrive at the appropriate imputation.

     5. In order to facilitate the above procedures and charges, all coordination, scheduling and
record keeping will be handled by the Administrative Assistant to the Chief Executive Officer.

     6. Corporate Aircraft shall be covered by aircraft liability insurance with limits of
liability of not less than $300 million per occurrence. The Company shall be provided a certificate
or certificates of insurance evidencing such liability coverage and naming the Company as an
additional insured. Coverage for loss or damage to property (including, without limitation, baggage
and personal effects) shall not be less than $50,000 per passenger. The policies shall contain a
waiver of subrogation against the Company, its officers, directors, agents and employees for losses
arising out of the use of Corporate Aircraft.

2exv10w3

 

EXHIBIT 10.3

DEX MEDIA, INC.

FINANCIAL PLANNING BENEFIT

     The Dex Media, Inc. Financial Planning Benefit (the “Financial Planning Benefit”) was adopted
by the Board of Directors of Dex Media, Inc. (the “Company”) on May 19, 2005. All the Company’s
officers are eligible for the Financial Planning Benefit. Participation in the Financial Planning
Benefit is voluntary. Pursuant to the Financial Planning Benefit, the Company will engage U.S.
Trust to provide financial planning services to the Company’s officers. Such services may include
financial status assessment, lifestyle planning, investment planning, estate planning and insurance
planning. Such services will not include tax preparation or the drafting of legal documents. Each
officer who selects to participate in the Financial Planning Benefit will: (i) receive an annual
benefit in an amount not to exceed $5,000 and (ii) receive imputed income in an amount equal to
such annual benefit.

1exv10w4

 

EXHIBIT 10.4

DEX MEDIA, INC.

2005 SENIOR EXECUTIVE INCENTIVE BONUS PLAN PERFORMANCE TARGETS

     On May 19, 2005, the Compensation Committee (the “Compensation Committee”) of the Board of
Directors of Dex Media, Inc. (the “Company”) established the performance targets relating to the
Company’s Senior Executive Incentive Bonus Plan (the “Bonus Plan”) for the year ending December 31,
2005. For the year ending December 31, 2005, the Compensation Committee has determined that 50% of
the award under the Bonus Plan will be payable based on the Company’s attainment of certain targets
relating to the Company’s earnings before interest, taxes, depreciation and amortization (“EBITDA”)
and 50% will be payable based on the Company’s attainment of certain targets relating to the
Company’s sold revenue. The Bonus Plan was previously filed as Exhibit 10.1 to the Company’s
Current Report on Form 8-K dated February 17, 2005.

1exv4w1

 

EXHIBIT 4.1

 

 

AMENDMENT NO. 1 TO RIGHTS AGREEMENT

     This Amendment no. 1 to Rights Agreement is entered into as of May 23, 2005 (the
“Amendment”) by and between Aspect Medical Systems, Inc., a Delaware corporation (the “Company”)
and EquiServe Trust Company, N.A., a national banking association, as Rights Agent (the “Rights
Agent”).

     Whereas, the Company and the Rights Agent are parties to that certain Rights
Agreement dated November 29, 2004 (the “Rights Agreement”);

     Whereas, the Rights (as defined in the Whereas clause at the beginning of
the Rights Agreement) are still redeemable; and

     Whereas, the Company has directed the Rights Agent to enter into this Amendment No. 1
pursuant to Section 27 of the Rights Agreement;

     Now, Therefore, in consideration of the premises and mutual agreements set forth
herein, the parties agree as follows:

     1. Section 1(r) of the Rights Agreement is hereby amended by deleting such section in its
entirety and substituting therefore the following:

	 	“(r)   	 “Exempted Person” shall mean Boston Scientific Corporation, a Delaware
corporation (“Boston Scientific”), which as of November 29, 2004, beneficially owned
an aggregate of 4,985,730 shares of the Company’s Common Stock, representing
approximately 24% of the Common Stock outstanding as of November 29, 2004, unless and
until such time as Boston Scientific, together with its Affiliates and Associates,
directly or indirectly, becomes the Beneficial Owner of more than 29.5% of the Common
Stock then outstanding (other than under circumstances described in the second
sentence of Section 1(a) hereof (replacing for this purpose all references in Section
1(a) to 17.5% with 29.5%)), in which event, Boston Scientific immediately shall cease
to be an Exempted Person.”

     2. Section 3(a) of the Rights Agreement is hereby amended by deleting such section in its
entirety and substituting therefore the following:

	 	“(a)    	Until the earlier of (i) the close of business on the tenth Business Day
(or such later date as may be determined by the Board) after the Stock Acquisition
Date (or, if the tenth Business Day after the Stock Acquisition Date occurs before
the Record Date, the close of business on the Record Date), or (ii) the close of
business on the tenth Business Day (or such later date as may be determined by action
of the Board) after the date that a tender or exchange offer (other than a Permitted
Offer) by any Person (other than the Company, any Subsidiary of the Company, any
employee benefit plan of the Company or of any Subsidiary of the Company, or any
Person organized, appointed or established by the Company for or pursuant to the
terms of any such plan) is first published or sent or given within the meaning of
Rule 14d-2 of the General Rules and Regulations under the

 

 

	 	   	Exchange Act, if upon consummation thereof, such Person would be the Beneficial
Owner of 17.5% or more of the shares of Common Stock then outstanding, or, in the
case of an Exempted Person, 29.5% or more of the shares of Common Stock then
outstanding, (the earlier of (i) and (ii) being herein referred to as the
“Distribution Date”), (x) the Rights will be evidenced by the certificates for the
Common Stock registered in the names of the holders of the Common Stock (which
certificates for Common Stock shall be deemed also to be certificates for Rights)
and not by separate certificates, and (y) the Rights will be transferable only in
connection with the transfer of the underlying shares of Common Stock (including a
transfer to the Company). As soon as practicable after the Distribution Date, the
Rights Agent will send by first-class, insured, postage prepaid mail, to each record
holder of the Common Stock as of the close of business on the Distribution Date, at
the address of such holder shown on the records of the Company, one or more rights
certificates, in substantially the form of Exhibit B hereto (the “Rights
Certificates”), evidencing one Right for each share of Common Stock so held, subject
to adjustment as provided herein. With respect to certificates for the Common Stock
outstanding as of the close of business on the Record Date, until the Distribution
Date, the Rights will be evidenced by such certificates for the Common Stock and the
registered holders of the Common Stock shall also be the registered holders of the
associated Rights. In addition, in connection with the issuance or sale of shares
of Common Stock following the Distribution Date and prior to the redemption or
expiration of the Rights, the Company (i) shall, with respect to shares of Common
Stock so issued or sold pursuant to the exercise of stock options or under any
employee benefit plan or arrangement, or upon the exercise, conversion or exchange
of securities granted or issued by the Company prior to the Distribution Date, and
(ii) may, in any other case, if deemed necessary or appropriate by the Board, issue
Rights Certificates representing the appropriate number of Rights in connection with
such issuance or sale; provided, however, that (x) no such Rights Certificate shall
be issued if, and to the extent that, the Company shall be advised by counsel that
such issuance would create a significant risk of material adverse tax consequences
to the Company or the Person to whom such Rights Certificate would be issued, and
(y) no such Rights Certificate shall be issued if, and to the extent that,
appropriate adjustment shall otherwise have been made in lieu of the issuance
thereof. In the event that an adjustment in the number of Rights per share of
Common Stock has been made pursuant to Sections 11(i) or 11(p) hereof, at the time
of distribution of the Rights Certificates, the Company shall make the necessary and
appropriate rounding adjustments (in accordance with Section 14(a) hereof) so that
Rights Certificates representing only whole numbers of Rights are distributed and
cash is paid in lieu of any fractional Rights. As of and after the Distribution
Date, the Rights will be evidenced solely by such Rights Certificates.

     3. The Rights Agreement, as supplemented and modified by this Amendment, together with the
other writings referred to in the Rights Agreement or delivered pursuant thereto which form a part
thereof, contain the entire agreement among the parties with respect to the

 

 

subject matter thereof and amend, restate and supersede all prior and contemporaneous
arrangements or understandings with respect thereto.

     4. Upon the effectiveness of this Amendment, on and after the date hereof, each reference in
the Rights Agreement to “this Agreement, “hereunder,” “hereof,” “herein” or words of like import,
shall mean and be a reference to the Rights Agreement, as amended hereby. Except as specifically
amended above, the Rights Agreement shall remain in full force and effect and is hereby ratified
and confirmed.

     5. This Amendment shall be governed by the laws of the State of Delaware, exclusive of its
choice of law and conflicts of law rules.

     6. This Amendment may be executed in any number of counterparts, and each such
counterpart shall be deemed to be an original instrument, but all such counterparts
together shall constitute but one agreement.

[end of text]

 

 

     In Witness Whereof, the parties have duly executed this Amendment No. 1 to Rights
Agreement, intending that it be executed under seal, as of the date first written above.

	 	 	 	 	 	 	 	 	 	 	 
	ASPECT MEDICAL SYSTEMS, INC.	 	 	 	EQUISERVE TRUST COMPANY, N.A.
AS RIGHTS AGENT
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Nassib G. Chamoun
	 	 	 	By:	 	/s/ Carol Mulvey-Eori	 	
	 	 	 	 	 	 	 	 	 	 	 
	

	 	Nassib Chamoun
	 	 	 	 	 	Name: Carol Mulvey-Eori	 	 
	

	 	President and Chief Executive Officer
	 	 	 	 	 	Title: Managing Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]